Amphastar Pharmaceuticals, Inc. (AMPH) stock
AMPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3033% below fair value
$28.87+0.27 (+0.94%)
Close on Nov 12, 2026Market cap $1.23BP/E 13.1Yield –
Amphastar Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Amphastar Pharmaceuticals's cash was $230.63M at Sep 30, 2026. For fiscal 2025 it was $282.81M, up 27.5% from the year before. Over ten years it grew 15.7% a year on average. The highest annual figure on record is $282.81M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $282.81M | +27.5% |
| FY2024 | Dec 31, 2024 | $221.88M | -13.7% |
| FY2023 | Dec 31, 2023 | $257.04M | +46.0% |
| FY2022 | Dec 31, 2022 | $176.00M | +28.6% |
| FY2021 | Dec 31, 2021 | $136.91M | +27.4% |
| FY2020 | Dec 31, 2020 | $107.48M | +23.2% |
| FY2019 | Dec 31, 2019 | $87.23M | -4.2% |
| FY2018 | Dec 31, 2018 | $91.03M | +29.9% |
| FY2017 | Dec 31, 2017 | $70.09M | -3.8% |
| FY2016 | Dec 31, 2016 | $72.88M | +10.3% |
| FY2015 | Dec 31, 2015 | $66.07M | -2.6% |
| FY2014 | Dec 31, 2014 | $67.83M | +26.6% |
| FY2013 | Dec 31, 2013 | $53.59M | +6.7% |
| FY2012 | Dec 31, 2012 | $50.21M | -6.6% |
| FY2011 | Dec 31, 2011 | $53.74M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $230.63M | -16.6% |
| Q2 FY2026 | Jun 30, 2026 | $290.12M | +25.1% |
| Q1 FY2026 | Mar 31, 2026 | $291.95M | +23.1% |
| Q4 FY2025 | Dec 31, 2025 | $282.81M | +27.5% |
| Q3 FY2025 | Sep 30, 2025 | $276.44M | +10.3% |
| Q2 FY2025 | Jun 30, 2025 | $231.99M | +6.4% |
| Q1 FY2025 | Mar 31, 2025 | $237.12M | -18.2% |
| Q4 FY2024 | Dec 31, 2024 | $221.88M | -13.7% |
| Q3 FY2024 | Sep 30, 2024 | $250.73M | -17.6% |
| Q2 FY2024 | Jun 30, 2024 | $218.01M | +31.5% |
| Q1 FY2024 | Mar 31, 2024 | $289.79M | +50.1% |
| Q4 FY2023 | Dec 31, 2023 | $257.04M | +46.0% |
| Q3 FY2023 | Sep 30, 2023 | $304.14M | +65.0% |
| Q2 FY2023 | Jun 30, 2023 | $165.82M | -9.7% |
| Q1 FY2023 | Mar 31, 2023 | $193.13M | +3.1% |
| Q4 FY2022 | Dec 31, 2022 | $176.00M | +28.6% |
| Q3 FY2022 | Sep 30, 2022 | $184.32M | +60.5% |
| Q2 FY2022 | Jun 30, 2022 | $183.63M | +34.7% |
| Q1 FY2022 | Mar 31, 2022 | $187.25M | +62.3% |
| Q4 FY2021 | Dec 31, 2021 | $136.91M | +27.4% |
| Q3 FY2021 | Sep 30, 2021 | $114.87M | +14.1% |
| Q2 FY2021 | Jun 30, 2021 | $136.34M | +35.9% |
| Q1 FY2021 | Mar 31, 2021 | $115.37M | +67.4% |
| Q4 FY2020 | Dec 31, 2020 | $107.48M | +23.2% |
| Q3 FY2020 | Sep 30, 2020 | $100.65M | +0.5% |
| Q2 FY2020 | Jun 30, 2020 | $100.35M | -19.8% |
| Q1 FY2020 | Mar 31, 2020 | $68.91M | -17.8% |
| Q4 FY2019 | Dec 31, 2019 | $87.23M | -4.2% |
| Q3 FY2019 | Sep 30, 2019 | $100.14M | +36.4% |
| Q2 FY2019 | Jun 30, 2019 | $125.07M | +137.1% |
| Q1 FY2019 | Mar 31, 2019 | $83.80M | +41.5% |
| Q4 FY2018 | Dec 31, 2018 | $91.03M | +29.9% |
| Q3 FY2018 | Sep 30, 2018 | $73.43M | +3.0% |
| Q2 FY2018 | Jun 30, 2018 | $52.75M | -38.0% |
| Q1 FY2018 | Mar 31, 2018 | $59.24M | -23.7% |
| Q4 FY2017 | Dec 31, 2017 | $70.09M | -3.8% |
| Q3 FY2017 | Sep 30, 2017 | $71.31M | – |
| Q2 FY2017 | Jun 30, 2017 | $85.14M | – |
| Q1 FY2017 | Mar 31, 2017 | $77.64M | – |
| Q4 FY2016 | Dec 31, 2016 | $72.88M | – |
See a number that looks wrong?